Shannon Harrington, PhD, participated in a study showing a patient's race and ethnicity dramatically influenced their preferences about the care they receive at the end of their lives.
A clinical trial led by Dr. Ursula Matulonis and Dr. Joyce Liu showed a two-drug combination can signficantly improve benefit for women with ovarian cancer that has recurred after initial treatment.
Dr. William Kaelin commented on the cancer-stem-cell model, and the possibility of controlling cancer without killing it.
Rafael Irizarry, PhD, co-led a new study investigating all stages and types of cancers that appear to share a telltale signature of widespread changes to the epigenome.
Tags: BasicResearch, Genomics
Former Red Sox pitcher and Dana-Farber patient Curt Schilling announced he will return to ESPN as a studio analyst after he took a leave of absence following his cancer diagnosis.
Tags: OralCancer, HeadNeckCancers
Former Dana-Farber/Boston Children’s Cancer and Blood Disorders Center patient Kate Franklin spent the summer interning in the lab of Dr. Loren Walensky, who treated her for leukemia when she was a child.
Steven Chang led a study showing robotic surgery for
prostate cancer may have led to changes in the number of surgeons performing
prostate removals and in the overall cost.
A new program called CaNCURE is a unique partnership between the Initiative
to Eliminate Cancer Disparities at Dana-Farber/Harvard Cancer Center and
Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: